Synthesis and anti-parasitic activity of N-benzylated phosphoramidate Mg2+-chelating ligands. 2020

Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
Department of Chemistry, Rhodes University, Grahamstown 6140, South Africa; Department of Biochemistry and Microbiolgy, Rhodes University, Grahamstown 6140, South Africa.

A series of N-benzylated phosphoramidate esters, containing a 3,4-dihydroxyphenyl Mg2+-chelating group, has been synthesised in five steps as analogues of fosmidomycin, a Plasmodium falciparum 1-deoxy-1-d-xylulose-5-phosphate reductoisomerase (PfDXR) inhibitor. The 3,4-dihydroxyphenyl group effectively replaces the Mg2+-chelating hydroxamic acid group in fosmidomycin. The compounds showed very encouraging anti-parasitic activity with IC50 values of 5.6-16.4 µM against Plasmodium falciparum parasites and IC50 values of 5.2 - 10.2 µM against Trypanosoma brucei brucei (T.b.brucei). Data obtained from in silico docking of the ligands in the PfDXR receptor cavity (3AU9)5 support their potential as PfDXR inhibitors.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D010756 Phosphoric Acids Inorganic derivatives of phosphoric acid (H3PO4). Note that organic derivatives of phosphoric acids are listed under ORGANOPHOSPHATES. Pyrophosphoric Acids,Acids, Phosphoric,Acids, Pyrophosphoric
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005578 Fosfomycin An antibiotic produced by Streptomyces fradiae. Phosphonomycin,Fosfomycin Trometamol Salt,Fosfomycin Tromethamine,Monuril,Phosphomycin,Tromethamine, Fosfomycin
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial

Related Publications

Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
June 2013, ChemMedChem,
Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
January 2006, Bioorganic & medicinal chemistry letters,
Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
December 2006, Dalton transactions (Cambridge, England : 2003),
Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
January 2006, Molecular pharmaceutics,
Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
February 2023, Dalton transactions (Cambridge, England : 2003),
Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
January 1992, Nucleic acids symposium series,
Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
May 2019, The Journal of organic chemistry,
Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
March 2015, Journal of the American Chemical Society,
Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
January 2009, Inorganic chemistry,
Christiana M Adeyemi, and Heinrich C Hoppe, and Michelle Isaacs, and Dumisani Mnkandhla, and Kevin A Lobb, and Rosalyn Klein, and Perry T Kaye
December 2014, Inorganic chemistry,
Copied contents to your clipboard!